drug

Antipsychotic drugs

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Central South University
3 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

3
The ATP Project (Antipsychotic-TEP-Psychosis)
NCT06651112—Not Yet Recruiting
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
NCT05039489—Completed
Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders
NCT04218981—Completed

KOLs & investigators

4
Stephen J Heishman, Ph.D.KOL score 5
Wenbin GuoKOL score 5
Maggie Hahn, MD
Kevin Zemmour, MD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Central South University
company
trial
The ATP Project (Antipsychotic-TEP-Psychosis)
trial
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
NA
trial
Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders
NA
trial
indication
Schizophrenia
indication
Metabolic Disease
indication
Ketosis
indication
First Episose Psychosis
indication
KOL
Stephen J Heishman, Ph.D.
KOL score 5
person
Wenbin Guo
KOL score 5
person
Maggie Hahn, MD
KOL score —
person
Kevin Zemmour, MD
KOL score —
person